lifestyle.marketresearchjournals.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
SHIFAMED, LLC / SPRIG CONSULTING, LLC
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
April 8, 2026
First Patient Treated in Myra Vision’s U.S. ADAPT Clinical Study for Glaucoma
January 27, 2026
Akura Medical, a Shifamed Portfolio Company, Closes $53 Million in Series C Financing
December 1, 2025